Inventor
Jérôme Michel Claude FORTIN
Inventor
FR
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
Y02ATechnologies for adaptation to climate change14%
PatentTitleYear
11,795,149Substituted indoline derivatives as dengue viral replication inhibitors202311,702,426Macrocyclic deaza-purinones for the treatment of viral infections202311,407,715Substituted indoline derivatives as dengue viral replication inhibitors202211,312,727Macrocyclic flu endonuclease inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to JANSSEN PHARMACEUTICALS INC (2)· patent assignee history
2022–2023Patents assigned to UNIV LEUVEN KATH (2)· patent assignee history
2022Patents assigned to JANSSEN BIOPHARMA INC (1)· patent assignee history
2022–2023Based in FR· patent location history
2023Patents assigned to JANSSEN SCIENCES IRELAND UNLIMITED CO (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICALS INC | 2 | 2022–2023 |
| UNIV LEUVEN KATH | 2 | 2022–2023 |
| JANSSEN BIOPHARMA INC | 1 | 2022 |
| JANSSEN SCIENCES IRELAND UNLIMITED CO | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 4 | 2022–2023 |